Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by Str8Shuteron Apr 27, 2020 11:43am
168 Views
Post# 30957738

RE:Broker Preferencing Allowed on TSX

RE:Broker Preferencing Allowed on TSXTook a screenshot of recent SZLS trades on tmxmoney a few minutes ago, and annotated it.  I find it interesting to observe the extent to which broker preferencing is used in the execution of trades.  Still wondering why this practice is reportedly not allowed on the US. exchanges. 

User image


Str8Shuter wrote:
Have you ever noticed how remarkably often blocks of shares trade on the TSX for any given company when the Buyer and the Seller are from the same trading house (e.g. TD Securities Inc., Desjardins Securities Inc., BMO Nesbitt Burns Inc., etc., etc..)??  TMX provides disclosure for this questionable feature on their website:

https://www.tsx.com/trading/tsx-alpha-exchange/order-types-and-features/order-types
"Broker preferencing is a unique feature of Canadian markets. In general, TSX, TSXV and TSXA follows Price/Broker/Time priority when matching orders. This means incoming orders to a trading venue to match with other orders from the same dealer ahead of similarly priced orders from other dealers, before time priority is considered. An order must be attributed (i.e. not marked as Anonymous) in order to participate in broker preferencing. Jitney orders are excluded from broker preferencing opportunities."

That might sound reasonable on the surface, but it strikes me as patently unfair.  It would seem to definitely benefit the broker in all cases, whereas their clients could either benefit or be harmed by the practice.  I can't help but wonder why it is reportedly a "unique" feature of Cdn markets.

Would be interested to hear any other opinions though.


Bullboard Posts